Rep. Earl “Buddy” Carter (R-GA) yesterday introduced a bill that would require hospitals participating in the 340B drug savings program to report their low-income utilization rate for outpatient services. The new reporting requirement is modeled after the current Medicaid disproportionate share hospital program low-income utilization rate (LIUR) reporting requirement, which is based on inpatient data. Currently, state Medicaid programs are required to report to the Centers for Medicare & Medicaid Services through the Medicaid DSH audit and reporting process the LIUR for hospitals receiving Medicaid DSH payments. Carter’s bill would require 340B DSH hospitals report to the Health Resources and Services Administration a LIUR for outpatient services based on Medicaid revenues and charity care provided by 340B DSH hospitals and their registered 340B outpatient sites that is not collected by any federal program. HRSA would be required to submit an annual report to Congress regarding the information submitted by the 340B DSH hospitals. “We have concerns the bill would impose new overly burdensome reporting requirements on hospitals requesting data that is not accessible in nature,” said an AHA spokesperson. “Such reporting requirements would not provide meaningful transparency nor tell the real story of the value of the 340B program.”

Headline
The 4th U.S. Circuit Court of AppealsMay 28 agreed to rehear challenges to 340B contract pharmacy laws from West Virginia and Maryland. In April, a three-judge…
Headline
Rep. Randy Feenstra, R-Iowa, introduced the Rural Maternity Options for Medical Support Act on May 19. The bill would guarantee that beds used solely for labor…
Headline
The House Education and Workforce Committee May 21 unanimously passed the Transparency in Billing Act (H.R. 8684). The bill would require off-campus hospital…
Headline
The Wall Street Journal today published a letter to the editor from AHA General Counsel Chad Golder responding to a May 7 editorial criticizing the 340B Drug…
Headline
The AHA today urged Eli Lilly to abandon its 340B Drug Pricing Program claims-data policy and work with the AHA to develop a functional third-party…
Headline
The AHA April 29 urged House and Senate appropriations committee leaders to fund health care programs that have been successful in improving access to care for…